JP2017500885A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017500885A5 JP2017500885A5 JP2016552457A JP2016552457A JP2017500885A5 JP 2017500885 A5 JP2017500885 A5 JP 2017500885A5 JP 2016552457 A JP2016552457 A JP 2016552457A JP 2016552457 A JP2016552457 A JP 2016552457A JP 2017500885 A5 JP2017500885 A5 JP 2017500885A5
- Authority
- JP
- Japan
- Prior art keywords
- pancreatin
- solvent
- mpa
- organic solvent
- hildebrand solubility
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010019160 Pancreatin Proteins 0.000 claims 27
- 229940055695 pancreatin Drugs 0.000 claims 27
- 238000000034 method Methods 0.000 claims 24
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 19
- 239000000203 mixture Substances 0.000 claims 19
- 239000003960 organic solvent Substances 0.000 claims 19
- 239000002904 solvent Substances 0.000 claims 18
- 239000003125 aqueous solvent Substances 0.000 claims 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 12
- 239000000243 solution Substances 0.000 claims 11
- 230000000694 effects Effects 0.000 claims 9
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims 8
- 239000007853 buffer solution Substances 0.000 claims 7
- 238000001035 drying Methods 0.000 claims 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 4
- 239000004367 Lipase Substances 0.000 claims 4
- 102000004882 Lipase Human genes 0.000 claims 4
- 108090001060 Lipase Proteins 0.000 claims 4
- 239000000872 buffer Substances 0.000 claims 4
- 235000019421 lipase Nutrition 0.000 claims 4
- 239000008188 pellet Substances 0.000 claims 4
- 230000001376 precipitating effect Effects 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- 239000004382 Amylase Substances 0.000 claims 3
- 102000013142 Amylases Human genes 0.000 claims 3
- 108010065511 Amylases Proteins 0.000 claims 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims 3
- 108091005804 Peptidases Proteins 0.000 claims 3
- 239000004365 Protease Substances 0.000 claims 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims 3
- 235000011130 ammonium sulphate Nutrition 0.000 claims 3
- 235000019418 amylase Nutrition 0.000 claims 3
- 235000019626 lipase activity Nutrition 0.000 claims 3
- 239000006228 supernatant Substances 0.000 claims 3
- 239000000725 suspension Substances 0.000 claims 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical group CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- 239000012062 aqueous buffer Substances 0.000 claims 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims 2
- 238000002523 gelfiltration Methods 0.000 claims 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 2
- 238000003756 stirring Methods 0.000 claims 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 229920005654 Sephadex Polymers 0.000 claims 1
- 241000282887 Suidae Species 0.000 claims 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 230000029936 alkylation Effects 0.000 claims 1
- 238000005804 alkylation reaction Methods 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 229960003624 creatine Drugs 0.000 claims 1
- 239000006046 creatine Substances 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 230000005865 ionizing radiation Effects 0.000 claims 1
- 239000006193 liquid solution Substances 0.000 claims 1
- 239000006194 liquid suspension Substances 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- 239000004005 microsphere Substances 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 230000004962 physiological condition Effects 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- -1 sachets Substances 0.000 claims 1
- 230000003381 solubilizing effect Effects 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361900092P | 2013-11-05 | 2013-11-05 | |
| US61/900,092 | 2013-11-05 | ||
| PCT/US2014/063984 WO2015069677A1 (en) | 2013-11-05 | 2014-11-05 | High potency pancreatin pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017500885A JP2017500885A (ja) | 2017-01-12 |
| JP2017500885A5 true JP2017500885A5 (enExample) | 2017-11-09 |
Family
ID=53042009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552457A Pending JP2017500885A (ja) | 2013-11-05 | 2014-11-05 | 高力価パンクレアチン医薬組成物 |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP3613429A1 (enExample) |
| JP (1) | JP2017500885A (enExample) |
| KR (1) | KR20170052520A (enExample) |
| CN (1) | CN106659773A (enExample) |
| AU (1) | AU2014346930A1 (enExample) |
| BR (1) | BR112016000658A2 (enExample) |
| CA (1) | CA2915671A1 (enExample) |
| ES (1) | ES2834483T3 (enExample) |
| HK (1) | HK1222325A1 (enExample) |
| IL (3) | IL243435B (enExample) |
| MX (1) | MX2016000480A (enExample) |
| RU (1) | RU2015155470A (enExample) |
| WO (1) | WO2015069677A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1319655B1 (it) | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
| AU2008218595B2 (en) | 2007-02-20 | 2012-05-24 | Allergan Therapeutics LLC | Stable digestive enzyme compositions |
| WO2009109856A2 (en) | 2008-03-07 | 2009-09-11 | Axcan Pharma Inc. | Method for detecting infectious parvovirus in pharmaceutical preparations |
| UA111726C2 (uk) | 2010-10-01 | 2016-06-10 | Апталіс Фарма Лімітед | Препарат панкреліпази низької сили з кишковорозчинним покриттям |
| MX351014B (es) | 2011-08-08 | 2017-09-28 | Aptalis Pharma Ltd | Metodo para la prueba de disolucion de composiciones solidas que contienen enzimas digestivas. |
| US10184121B2 (en) | 2013-06-28 | 2019-01-22 | Allergan Pharmaceuticals International Limited | Methods for removing viral contaminants from pancreatic extracts |
| US20160152968A1 (en) | 2013-07-22 | 2016-06-02 | Aptalis Pharma Ltd. | High potency pancreatin pharmaceutical compositions |
| CN106163544A (zh) | 2013-08-09 | 2016-11-23 | 阿勒根制药国际有限公司 | 适于经肠施用的消化酶组合物 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2751330A (en) * | 1952-08-27 | 1956-06-19 | Armour & Co | Use of a salt in the extraction slurry in recovering proteolytic enzymes from pancreas gland material |
| GB928654A (en) | 1960-10-25 | 1963-06-12 | Philips Nv | Improvements in or relating to the production of pancreatin |
| US3168448A (en) | 1963-01-07 | 1965-02-02 | Wilson & Co Inc | Process of preparing a lipolytic enzyme composition |
| DE2460334C3 (de) * | 1974-12-20 | 1979-09-06 | Hoechst Ag, 6000 Frankfurt | Verfahren zur Gewinnung von Insulin und Pankreatin aus Schweinepankreas |
| DE3377506D1 (en) * | 1982-12-30 | 1988-09-01 | Nordmark Arzneimittel Gmbh | Process for obtaining pancreatin |
| FR2603804B1 (fr) * | 1986-09-17 | 1989-10-27 | Jouveinal Sa | Lipases et extraits lipasiques, leur procede de preparation et leur application en therapeutique |
| DE3927286C2 (de) * | 1989-08-18 | 1997-07-24 | Roehm Gmbh | Wäßrige Enzym-Flüssigformulierungen |
| DE69634248T2 (de) | 1995-05-31 | 2006-01-12 | Medzyme N.V. | Zusammensetzungen zur verbesserung der verdaulichkeit und ausnutzung von nähestoffen |
| US5750104A (en) * | 1996-05-29 | 1998-05-12 | Digestive Care Inc. | High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith |
| DE19724845A1 (de) * | 1996-08-28 | 1998-03-05 | Solvay Pharm Gmbh | Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen |
| US20010046493A1 (en) | 2000-02-24 | 2001-11-29 | Alex Margolin | Lipase-containing composition and methods of use thereof |
| AR032392A1 (es) * | 2001-01-19 | 2003-11-05 | Solvay Pharm Gmbh | Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado. |
| CA2419572A1 (en) * | 2003-02-18 | 2004-08-18 | Axcan Pharma Inc. | High dosage protease formulation |
| US20060198838A1 (en) * | 2004-09-28 | 2006-09-07 | Fallon Joan M | Combination enzyme for cystic fibrosis |
| SI1809320T1 (sl) | 2004-10-14 | 2010-11-30 | Cystic Fibrosis Foundation Therapeutics Inc | Sestavki ki vsebujejo lipazo proteazo in amilazo za zdravljenje pankreasne insuficience |
| HUE031042T2 (en) | 2005-07-29 | 2017-06-28 | Abbott Laboratories Gmbh | Methods for producing pancreatin powder with low viral content |
| AU2008218595B2 (en) * | 2007-02-20 | 2012-05-24 | Allergan Therapeutics LLC | Stable digestive enzyme compositions |
| JP2013522284A (ja) * | 2010-03-19 | 2013-06-13 | アプタリス・ファーマ・カナダ・インコーポレイテッド | 胃耐性の酵素医薬組成物 |
| JP2013525488A (ja) * | 2010-05-03 | 2013-06-20 | アプタリス ファーマ リミテッド | 消化酵素混合物を含有するパンクレアチンを含むマイクロペレット組成物 |
| UA111726C2 (uk) * | 2010-10-01 | 2016-06-10 | Апталіс Фарма Лімітед | Препарат панкреліпази низької сили з кишковорозчинним покриттям |
| CN103060297B (zh) * | 2012-12-28 | 2014-06-25 | 青岛九龙生物医药有限公司 | 一种分离纯化胰蛋白酶的方法 |
| CN103060296B (zh) * | 2012-12-30 | 2014-05-21 | 青岛九龙生物医药有限公司 | 从动物胰脏中提取胰蛋白酶的方法 |
| US20160152968A1 (en) | 2013-07-22 | 2016-06-02 | Aptalis Pharma Ltd. | High potency pancreatin pharmaceutical compositions |
-
2014
- 2014-11-05 CN CN201480040273.7A patent/CN106659773A/zh active Pending
- 2014-11-05 EP EP19201877.8A patent/EP3613429A1/en not_active Withdrawn
- 2014-11-05 AU AU2014346930A patent/AU2014346930A1/en not_active Abandoned
- 2014-11-05 HK HK16110490.6A patent/HK1222325A1/zh unknown
- 2014-11-05 CA CA2915671A patent/CA2915671A1/en active Pending
- 2014-11-05 ES ES14859866T patent/ES2834483T3/es active Active
- 2014-11-05 KR KR1020167001052A patent/KR20170052520A/ko not_active Withdrawn
- 2014-11-05 BR BR112016000658A patent/BR112016000658A2/pt not_active Application Discontinuation
- 2014-11-05 JP JP2016552457A patent/JP2017500885A/ja active Pending
- 2014-11-05 WO PCT/US2014/063984 patent/WO2015069677A1/en not_active Ceased
- 2014-11-05 RU RU2015155470A patent/RU2015155470A/ru not_active Application Discontinuation
- 2014-11-05 EP EP14859866.7A patent/EP3003360B1/en not_active Revoked
- 2014-11-05 MX MX2016000480A patent/MX2016000480A/es unknown
-
2015
- 2015-12-31 IL IL243435A patent/IL243435B/en active IP Right Grant
-
2020
- 2020-05-11 IL IL274583A patent/IL274583B/en unknown
-
2021
- 2021-06-27 IL IL284419A patent/IL284419A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016101760A (ru) | Высокоэффективные фармацевтические композиции панкреатина | |
| RU2015155470A (ru) | Высокоэффективные фармацевтические композиции панкреатина | |
| US12084659B2 (en) | Modulatory polynucleotides | |
| Mout et al. | Direct cytosolic delivery of CRISPR/Cas9-ribonucleoprotein for efficient gene editing | |
| RU2413532C2 (ru) | Способ получения стерилизованного порошкообразного панкреатина | |
| RU2012142140A (ru) | Бета-пропиолактон для инактивации вирусов в фармацевтических препаратах фермента поджелудочной железы | |
| JP2022512395A (ja) | 分泌治療モダリティを送達するためのアネロソーム | |
| Ma et al. | Engineered exosomes with ATF5-modified mRNA loaded in injectable thermogels alleviate osteoarthritis by targeting the mitochondrial unfolded protein response | |
| JP2022513459A (ja) | タンパク質代替治療モダリティを送達するためのアネロソーム | |
| CN103919735B (zh) | 一种盐酸坦索罗辛缓释微丸及其制备方法 | |
| JP2022514501A (ja) | 細胞内治療モダリティを送達するためのアネロソーム | |
| Pretto et al. | Cowpea chlorotic mottle virus‐like particles as potential platform for antisense oligonucleotide delivery in posterior segment ocular diseases | |
| Zhou et al. | Spinal cord injury and inflammatory mediators: role in “fire barrier” formation and potential for neural regeneration | |
| CN112353940B (zh) | 一种用于预防或治疗抑郁症的药物及其应用 | |
| CN114569564A (zh) | 戈舍瑞林缓释微球组合物 | |
| CN110897998B (zh) | 一种同时载有疏水性药物和亲水性药物的基因工程多肽纳米水凝胶及其制备方法 | |
| CN105496982B (zh) | 一种壳聚糖片剂及其制备方法 | |
| CN104382873B (zh) | 一种吗替麦考酚酯分散片 | |
| Lv et al. | Broad‐spectrum antiviral effect of MoringaA‐loaded exosomes against IAV by mediating the GCN5‐TFEB‐autolysosome pathway | |
| Foster et al. | Effect of ursodiol on alginate/PLL nanoparticles with non-ionic surfactant for gene delivery | |
| JP6912072B2 (ja) | 前頭側頭型認知症の予防又は治療用医薬 | |
| Darveshwar Jagdeep et al. | Review on applications of polymers in pharmaceutical formulations | |
| Kim et al. | Therapeutic Potential of MicroRNAs and Their Nanoparticle-based Delivery in the Treatment of Liver Fibrosis | |
| Ghosh et al. | A review on pharmacological and therapeutic Insight of ozanimod for colon disease in nanostructure | |
| Dóra | Adenoviruses for better brain function |